Table 2.
Direction of Association |
GRADE Factors | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Outcome Domain | Number of Participants | Number of Studies | Diabetes Group Generally Had Better Outcomes | Tie in Direction of Association | Diabetes Group Generally Had Worse Outcomes | Phase of Investigation | Study Limitations | Inconsistency | Indirectness | Imprecision | Publication Bias | Effect Size | Exposure-Response Gradient | Overall Certainty in Evidence |
ROM | 2107 | 13 | 3 | 0 | 10 | Phase 2 | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ | ✕ | Very low |
Pain | 920 | 10 | 0 | 0 | 10 | Phase 2 | ✕ | ✓ | ✓ | ✕ | ✕ | ✕ | ✕ | Low |
Multidimensional scores | 1785 | 18 | 2 | 1 | 15 | Phase 2 | ✕ | ✓ | ✓ | ✕ | ✕ | ✓ | ✕ | Moderate |
NOTE. GRADE factor scoring: ✓ = no serious limitations (or present for moderate/large association size, exposure-response gradient); ✕ = serious limitations (or absent for moderate/large effect size, exposure-response gradient). Within the GRADE framework, a study is classed as phase 2 if it is “a cohort study that seeks to confirm independent associations between the prognostic factor and the outcome.”20(p71)